A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
RasCal Therapeutics, Inc.
RasCal Therapeutics, Inc.
M.D. Anderson Cancer Center
West German Study Group
University of Eastern Finland
Institut du Cancer de Montpellier - Val d'Aurelle
MPN Research Foundation
AstraZeneca
Università Vita-Salute San Raffaele
Yale University
M.D. Anderson Cancer Center
Wren Laboratories LLC
The University of Texas Health Science Center at San Antonio
Assistance Publique - Hôpitaux de Paris
AVEO Pharmaceuticals, Inc.
Universität Duisburg-Essen
Institute of Hematology & Blood Diseases Hospital, China
Lisata Therapeutics, Inc.
Sun Yat-sen University
Engeneic Pty Limited
Second Xiangya Hospital of Central South University
Shanghai Chest Hospital
AtlasMedx, Incorporated
Monteris Medical
IRCCS San Raffaele
University of California, San Francisco
The First Hospital of Jilin University
Stanford University
Stanford University
Pfizer
Institut Bergonié
University of Illinois at Chicago
Centre hospitalier de l'Université de Montréal (CHUM)
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Ain Shams University
Aveta Biomics, Inc.
St. Jude Children's Research Hospital
University of California, San Diego
AC Camargo Cancer Center
Monteris Medical
Monteris Medical
Universitaire Ziekenhuizen KU Leuven
Brown University
Wroclaw Medical University
Clinical Hospital Center Rijeka
IRCCS San Raffaele
M.D. Anderson Cancer Center
Norwegian University of Science and Technology
University of Pennsylvania
Weill Medical College of Cornell University
Kaohsiung Medical University Chung-Ho Memorial Hospital